Business Wire

Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design

5.11.2026 15:00:00 CET | Business Wire | Press release

Share

FSA/HSA-Eligible Recovery Boots Deliver Five Levels of Heat and Seven Levels of Compression, Available for Pre-Order Now

Hyperice, a high-performance wellness brand, today announced the launch of Normatec Elite Heat Legs, the newest innovation in the award-winning Normatec line and the first Normatec product to incorporate heat directly into its line of dynamic air compression therapy. As the 2024 launch of Normatec Elite signified a transformative leap forward in recovery technology, Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105782891/en/

Normatec Elite Heat demonstrates Hyperice’s relentless commitment to offering athletes and wellness enthusiasts alike the most comprehensive and intuitive recovery experiences in the world.

“Innovation has always been at the forefront of everything we do,” said Jim Huether, CEO of Hyperice. “Heat and dynamic air compression are two of the most trusted modalities in warm-up and recovery, and together they amplify each other. With Normatec Elite Heat Legs, we're bringing both technologies to our most advanced full-leg system in a premium, wireless design, so athletes can prepare and recover with one device. This is the most advanced Normatec we've ever built.”

Built to help anyone prepare before activity and accelerate recovery after, HyperHeat™ technology is integrated into the boots to help activate muscles, amplify and increase circulation, and soothe soreness. At the same time, Hyperice’s patented Normatec dynamic air compression delivers a restorative massage designed to reduce tension and swelling. The combination of both heat and compression drives the therapeutic benefits deeper into the legs for a more amplified experience. Users can choose from five levels of heat and seven levels of compression to personalize every session.

  • HyperHeat™ Technology: Integrated heat throughout the boots with five levels (102-125°F / 39-52°C).
  • Seven Levels of Dynamic Air Compression: With seven adjustable compression settings (40-110 mmHg) users are able to tailor their experience to their exact needs across five overlapping zones with gapless coverage.
  • HyperSync™ Technology: First introduced in the award-winning Normatec Go, HyperSync™ technology allows the user to mimic the massage pattern automatically on both legs or run separate sessions on each leg.
  • ZoneBoost™ Technology: Provides extra time and pressure in a particular zone of the user's choice.
  • Performance, Unplugged: A fully wireless design with up to one hour of battery life on max heat and compression settings and up to 10 hours on compression only.
  • Built for a Faster Reset: A new deflate button releases air quickly so users can transition out of a session faster.
  • Travel-Ready and Connected: TSA-approved for carry-on, with Bluetooth® connectivity to the Hyperice App enabling users to personalize their recovery experience.

Built on the Normatec Legacy

Designed by a PhD and a physician bioengineer, the Normatec product line replicates the natural muscle pumps of the body, the one-way valves of the venous system, and peristalsis (cyclical waves of compression) to efficiently mobilize fluid to improve circulation, reduce swelling and inflammation, and accelerate recovery. Hyperice reset the standard for dynamic air compression with the introduction of Normatec Elite in June 2024, eliminating external hoses and control units. Normatec Elite Hips followed in October 2025 as the first fully portable, standalone dynamic air compression device engineered for the hips, IT bands, and lower back. Scientific studies have shown benefits of using Normatec include a decrease in pain sensitivity1 and muscle fatigue after exercise2, and an increase in range of motion3.

“How I feel on Sunday comes down to what I do Monday through Saturday,” said Jayden Daniels, Hyperice athlete. “With heat and compression working together, I can warm up and recover in one session without changing my routine, and that makes a real difference in how my legs feel heading into game day.”

Normatec Elite Heat Legs are available for pre-order today at hyperice.com for $1,499 and CA$1,999 in Canada, with orders shipping the week of November 23rd. The device is available in short (recommended for 5'7" and under), standard (recommended for 5'7" to 6'4"), and tall (recommended for 6'4" and over) sizes, and is FSA/HSA eligible. Normatec Elite Heat Legs will roll out to international markets in early 2027.

About Hyperice

Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), contrast therapy (Hyperice X), and recovery footwear collaboration with Nike. Now, as a holistic high-performance wellness brand, Hyperice is designed for all, from the most elite athletes, leagues, and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company's Most Innovative Companies and a TIME Best Inventions winner, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance, and workplace wellness on a global scale. For more information, visit hyperice.com.

1Journal of Strength and Conditioning, 2015
2PLOS One Medical Journal, 2017
3Journal of Strength and Conditioning, 2014

View source version on businesswire.com: https://www.businesswire.com/news/home/20261105782891/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocodex Invests €15 Million in a New Industrial Platform for Live Biotherapeutic Products5.11.2026 16:04:00 CET | Press release

Biocodex, an independent French pharmaceutical company, announces a €15 million investment to develop an industrial platform in Beauvais, France, dedicated to Live Biotherapeutic Products (LBPs) derived from the microbiome. Building on more than 70 years of expertise in living microorganisms, microbiota, fermentation and pharmaceutical manufacturing, Biocodex aims to support its partners and, ultimately, its own programs, from research through to clinical and commercial production. The project aims to strengthen healthcare and industrial sovereignty in the field of next-generation microbiome-based therapies. Scientific advances in microbiome science are opening up new therapeutic perspectives, notably in oncology, inflammatory bowel diseases, certain rare diseases and women’s health. Moving from research to pharmaceutical production requires facilities adapted to living microorganisms and pharmaceutical requirements. Open to biotechnology companies worldwide, it will support LBP progra

Experian's New Documentary RECLAIM Shows How Financial Access and Innovation Are Creating Opportunity Around the World5.11.2026 16:00:00 CET | Press release

Short film follows consumers across three countries whose stories demonstrate the power of financial inclusion, innovation and resilienceKey highlights: New Experian documentary features five individuals from the United States, Brazil and the United Kingdom whose experiences illustrate the impact of financial access and opportunity. Documentary highlights examples spanning debt relief, financial education, credit empowerment and healthcare innovation. Stories showcase how Experian's products, services and social innovation can help consumers navigate challenges and pursue personal and financial goals. For years, Almir dreamed of meeting his granddaughter in the United States. But unresolved debt stood in the way. Thousands of miles away in Arizona, Elizabeth faced mounting medical expenses after a health crisis. In London, Rochelle worked to regain control of her finances while caring for family members. Their stories, and others like them, are at the heart of RECLAIM: Stories of Passi

Saudi Fund for Development Signs Six Development Loan Agreements Worth Over USD 403 Million with Syria5.11.2026 15:32:00 CET | Press release

The Saudi Fund for Development (SFD) has signed six concessional development loan agreements worth more than USD 403 million with the Syrian Arab Republic, marking a significant step in supporting the country’s recovery through the rehabilitation of essential infrastructure, restoration of vital public services and improvement of living conditions for communities affected by years of conflict. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261105350224/en/ HRH the Crown Prince and President of the Syrian Arab Republic Al-Sharaa witness signing of agreements (Photo: AETOSWire The agreements, signed under the directives of the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al Saud, Crown Prince and Prime Minister, reflect the Kingdom’s continued commitment to supporting Syria’s development priorities. The signing ceremony was witnessed by Hi

LPs Expect Private Markets Managers to Level Up in 2027: SS&C Intralinks Survey5.11.2026 15:00:00 CET | Press release

SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced the publication of the 2027 LP Survey. In association with Reuters Insights, SS&C Intralinks surveyed 400 professionals working in private markets, including 370 limited partners and allocators, to understand how the alternative investments market will change in the next 12 months.* “Alternatives once again delivered in 2026, and LPs are still committing capital, but their expectations of managers continue to rise,” said Ken Bisconti, general manager of SS&C Intralinks. “Technology and data capabilities now rank among the most important criteria for selecting managers, alongside investment strategy. Performance alone is no longer enough. For nearly one-third of allocators, a credible artificial intelligence (AI) strategy is now a prerequisite for allocating capital to a manager.” Key findings from the report include: Alternatives portfolios continue to outperform. 62% of respondents said their portfolios exceeded expectati

European Commission expands license for Alfasigma’s Jyseleca® (filgotinib) with approval of new indication, treatment of adults with axial spondylarthritis5.11.2026 15:00:00 CET | Press release

Jyseleca® (filgotinib) has received expanded approval for the treatment of patients with active axial spondylarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have not responded adequately to conventional therapy. EC approval follows a positive opinion from the CHMP in September 2026 and offers a new treatment option for people living with inadequately controlled axSpA in Europe. An application has been submitted to the MHRA for UK approval and is under review. In the OLINGUITO Phase 3 study, improvements in the signs and symptoms of axSpA – including spinal pain – were observed early and maintained over 52 weeks of treatment with filgotinib. This new indication builds on previous approvals for Jyseleca® for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis in Europe and the United Kingdom. The information contained within this press release is for the purpose of scientific exchange. It is intended for scientific, financia

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye